BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21493076)

  • 1. Comparing micellar, hemolytic, and antibacterial properties of di- and tricarboxyl dendritic amphiphiles.
    Maisuria BB; Actis ML; Hardrict SN; Falkinham JO; Cole MF; Cihlar RL; Peters SM; Macri RV; Sugandhi EW; Williams AA; Poppe MA; Esker AR; Gandour RD
    Bioorg Med Chem; 2011 May; 19(9):2918-26. PubMed ID: 21493076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing anti-HIV, antibacterial, antifungal, micellar, and cytotoxic properties of tricarboxylato dendritic amphiphiles.
    Macri RV; Karlovská J; Doncel GF; Du X; Maisuria BB; Williams AA; Sugandhi EW; Falkinham JO; Esker AR; Gandour RD
    Bioorg Med Chem; 2009 Apr; 17(8):3162-8. PubMed ID: 19307123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria.
    Falkinham JO; Macri RV; Maisuria BB; Actis ML; Sugandhi EW; Williams AA; Snyder AV; Jackson FR; Poppe MA; Chen L; Ganesh K; Gandour RD
    Tuberculosis (Edinb); 2012 Mar; 92(2):173-81. PubMed ID: 22209468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, critical micelle concentrations, and antimycobacterial properties of homologous, dendritic amphiphiles. Probing intrinsic activity and the "cutoff" effect.
    Sugandhi EW; Macri RV; Williams AA; Kite BL; Slebodnick C; Falkinham JO; Esker AR; Gandour RD
    J Med Chem; 2007 Apr; 50(7):1645-50. PubMed ID: 17346035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antimicrobial activity of symmetrical two-tailed dendritic tricarboxylato amphiphiles.
    Sugandhi EW; Falkinham JO; Gandour RD
    Bioorg Med Chem; 2007 Jun; 15(11):3842-53. PubMed ID: 17400459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavable cationic antibacterial amphiphiles: synthesis, mechanism of action, and cytotoxicities.
    Hoque J; Akkapeddi P; Yarlagadda V; Uppu DS; Kumar P; Haldar J
    Langmuir; 2012 Aug; 28(33):12225-34. PubMed ID: 22838496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antistaphylococcal activity of N-substituted-1H-benzimidazole-sulphonamides.
    Püsküllü MO; Yildiz S; Göker H
    Arch Pharm (Weinheim); 2010 Jan; 343(1):31-9. PubMed ID: 19927309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of long-chain, water-soluble, dendritic tricarboxylato amphiphiles.
    Williams AA; Sugandhi EW; Macri RV; Falkinham JO; Gandour RD
    J Antimicrob Chemother; 2007 Mar; 59(3):451-8. PubMed ID: 17242037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY; Wang GC; Zhao YB; Xu GL; Hao XY; Han J; Zhao Q
    J Ethnopharmacol; 2008 Nov; 120(2):287-90. PubMed ID: 18804522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI; García-Cañas A; García-Hierro P; Rodríguez-Salvanés F
    J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.
    Torrico M; Giménez MJ; González N; Alou L; Sevillano D; Cafini F; Prieto J; Cleeland R; Aguilar L
    Int J Antimicrob Agents; 2010 Feb; 35(2):131-7. PubMed ID: 20006469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).
    Kim HY; Wiles JA; Wang Q; Pais GC; Lucien E; Hashimoto A; Nelson DM; Thanassi JA; Podos SD; Deshpande M; Pucci MJ; Bradbury BJ
    J Med Chem; 2011 May; 54(9):3268-82. PubMed ID: 21425851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercus infectoria: a candidate for the control of methicillin-resistant Staphylococcus aureus infections.
    Chusri S; Voravuthikunchai SP
    Phytother Res; 2008 Apr; 22(4):560-2. PubMed ID: 18338770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
    Brinch KS; Tulkens PM; Van Bambeke F; Frimodt-Møller N; Høiby N; Kristensen HH
    J Antimicrob Chemother; 2010 Aug; 65(8):1720-4. PubMed ID: 20534628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
    Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
    Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1.
    Bremner JB; Keller PA; Pyne SG; Boyle TP; Brkic Z; David DM; Robertson M; Somphol K; Baylis D; Coates JA; Deadman J; Jeevarajah D; Rhodes DI
    Bioorg Med Chem; 2010 Apr; 18(7):2611-20. PubMed ID: 20236828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
    Hardej D; Ashby CR; Khadtare NS; Kulkarni SS; Singh S; Talele TT
    Eur J Med Chem; 2010 Dec; 45(12):5827-32. PubMed ID: 20947220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.